Skip links

Member of the

Learn more
Instagram Youtube Facebook-square

Type and hit enter

Published in: Information Disclosure

Material Information or Facts regarding the Reporting of Changes to the Board of Directors of Controlled Entity

Author
Published on:

Referring to Financial Service Authority (Otoritas Jasa Keuangan – “OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Information or Facts by Issuer or Public Company as partially amended by OJK Regulation No. 45 of 2024 on the Development and Strengthening of Issuers and Public Companies (“POJK 31/2015”) and Annex to the Board of Directors’ Decree of PT Bursa Efek Indonesia No. Kep-00066/BEI/09-2022 on Amendments to Regulation No. I-E on the Information Submission Obligation, we, PT Pyridam Farma Tbk (the “Company”) hereby inform the following material information:

  1. Date of Occurrence
    March 28, 2025.
  2. Type of Material Information or Fact
    Information or other material facts as referred to in Article 6 (cc) POJK 31/2015, in the form of other material information or facts.
  3. Details of Material Information or Fact
    On 28 March 2025, a report has been lodged to ASIC (Australian Securities and Investments Commission) regarding the change of Director in the Company’s controlled subsidiaries, namely:
    1. Probiotec Pty Ltd;
    2. A.C.N. 010 040 598 Pty Ltd;
    3. ABS (Aus) Pty Ltd;
    4. Australian Dairy Proteins Pty Ltd;
    5. Biotech Pharmaceuticals Australia Pty Ltd;
    6. Biotech Pharmaceuticals Pty Ltd;
    7. L.J.M. Marketing Services Pty Ltd;
    8. LJM (NSW) Pty Ltd;
    9. Milton Pharmaceuticals Pty Ltd;
    10. Probiotec Multipack Pty Ltd;
    11. Probiotec (NSW) Pty Ltd;
    12. Probiotec (QLD) Pty Limited;
    13. Probiotec Nutritionals Pty Limited;
    14. Probiotec Pharma Pty Limited;
    15. Probiotec Pharmaceuticals Pty Limited;
    16. South Pack Laboratories (Aust) Pty Ltd;
    17. Wille Labs Generics Pty Ltd.


    which are now held by Sinta Lestari Ningsih and Matthew William Edward Bamford, each as a Director.
    The reason for the changes is to promote growth of the Company’s controlled subsidiaries.

  4. Impact of the Material Information or Fact
    There is no material impact from the event, information, or material fact on the Company’s operational activities, legal matters, or business continuity. 

Similar information is also submitted by the Company through IDX’s Website and reported to the OJK.

Jakarta, 08 April 2025
PT Pyridam Farma Tbk
Corporate Secretary

You may also like

Leave a comment